OpenScholar

Search results

19 results found

Single duplex DNA sequencing with CODEC detects mutations with high sensitivity

Publication: Journal Article

Bae, Jin H., Ruolin Liu, Eugenia Roberts, Erica Nguyen, Shervin Tabrizi, Justin Rhoades, Timothy Blewett, et al. 2023. “Single Duplex DNA Sequencing With CODEC Detects Mutations With High Sensitivity”. Nat Genet.

FDX1 regulates cellular protein lipoylation through direct binding to LIAS

Publication: Journal Article

Dreishpoon, Margaret B, Nolan R Bick, Boryana Petrova, Douglas M Warui, Alison Cameron, Squire J Booker, Naama Kanarek, Todd R Golub, and Peter Tsvetkov. 2023. “FDX1 Regulates Cellular Protein Lipoylation through Direct Binding to LIAS”. J Biol Chem 299 (9).

Heejo Choi

Person: Computational Biologist

I am a computational biologist interested in the integration, interpretation, and visualization of data elucidating cancer dependencies in the context of the tumor microenvironment.

Andrea Clocchiatti

Person: Research Scientist

I am a research scientist interested in identifying cancer vulnerabilities in vivo linked to the complex ecosystem of cancer microenvironment.

Narsis Attar

Person: Postdoctoral Fellow

Daniel Ardeljan

Person: Postdoctoral Fellow

FDX1 regulates cellular protein lipoylation through direct binding to LIAS

Publication: Journal Article

Dreishpoon, Margaret B., Nolan R. Bick, Boryana Petrova, Douglas M. Warui, Alison Cameron, Squire J. Booker, Naama Kanarek, Todd R. Golub, and Peter Tsvetkov. 2023. “FDX1 Regulates Cellular Protein Lipoylation through Direct Binding to LIAS”. BioRxiv.

Translation of non-canonical open reading frames as a cancer cell survival mechanism in childhood medulloblastoma

Publication: Journal Article

Hofman, Damon A., Jorge Ruiz-Orera, Ian Yannuzzi, Rakesh Murugesan, Adam Brown, Karl R. Clauser, Alexandra L. Condurat, et al. 2023. “Translation of Non-Canonical Open Reading Frames As a Cancer Cell Survival Mechanism in Childhood Medulloblastoma”. BioRxiv.

The PTPN2/PTPN1 inhibitor ABBV-CLS-484 unleashes potent anti-tumour immunity

Publication: Journal Article

Baumgartner, Christina K., Hakimeh Ebrahimi-Nik, Arvin Iracheta-Vellve, Keith M. Hamel, Kira E. Olander, Thomas G. R. Davis, Kathleen A. McGuire, et al. 2023. “The PTPN2/PTPN1 Inhibitor ABBV-CLS-484 Unleashes Potent Anti-Tumour Immunity”. Nature 622 (7984): 850-62.